(Nov 28): Moderna Inc Chief Medical Officer Paul Burton said he suspects the new Omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year.
"We should know about the ability of the current vaccine to provide protection in the next couple of weeks," Burton said Sunday on the BBC 's "Andrew Marr Show".
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really going to be available in large quantities," he said. "The remarkable thing about the mRNA vaccines, the Moderna platform, is that we can move very fast," he said.
The Cambridge, Massachusetts-based biotech company mobilised "hundreds" of staff early on Thursday, Thanksgiving Day in the US, after news of the Omicron variant spread.
Protection should still exist, depending on how long ago a person was vaccinated, and for now the best advice is to take one of the current Covid-19 vaccines, Burton said.
"If people are on the fence, and you haven't been vaccinated, get vaccinated," he said. "This is a dangerous looking virus, but I think we have many tools in our armamentarium now to fight it."
The emergence of the Omicron strain has seen countries rush to clamp down on travel from southern Africa. Fears that it could exacerbate a winter Covid surge in the northern hemisphere and undermine a global economic recovery sent a wave of risk aversion across global markets Friday that continued on Sunday, when the Middle East opened for the week.
Moderna said in a release on Friday that it was working rapidly to test the current vaccine against the Omicron variant, and studying two booster candidates.
"Since early 2021, Moderna has advanced a comprehensive strategy to anticipate new variants of concern," the company said. "The company has repeatedly demonstrated the ability to advance new candidates to clinical testing in 60 to 90 days."
- A New US Airline Ready For Takeoff, Another One Bites The Dust
- State media says new tactical weapons test overseen by North Korean leader
- Sanofi admitted Dengvaxia risks as early as 2015: PAO
- Why the world needs more than one Ebola vaccine
- Google venture arm backs UK universal flu vaccine company
- BILL GATES: A new kind of terrorism could wipe out 30 million people -- and we are not prepared
- As New York struggles to undo the lies of anti-vaxers, moms step in to help
- Trying to convince ultra-Orthodox Jews to vaccinate, New York messes up the Yiddish
- Do adults need the measles vaccine? How to know if you're protected
- As measles returns, U.S. states look to cut vaccine exemptions
- GSK says vaccine business president to leave by year-end
- 2022 World Cup final in Qatar to be played on 18 December
- Google will open a new $1 billion dollar campus in NYC
- Google Will Spend $1 Billion For New York City Campus On Hudson River
- Fed’s Bullard Says He Would Take Chair Job, if Ever Offered It
- Google to expand New York City presence: What we know
- Fed’s Bullard Says He Would Take Chair Job, if Ever Offered
- GE CEO Jeff Immelt Says He’s Ready For Trump
- Tech Deals Bring New Challenges to M&A
- These new initiatives are helping more women start businesses and get funded
Moderna says new vaccine for Omicron may be ready in early 2022 have 553 words, post on www.theedgemarkets.com at November 29, 2021. This is cached page on Business News. If you want remove this page, please contact us.